456408 Consumner Co-Payments for Subsidised Medicines: Impact on Access and Health Outcomes

Roughead, Elizabeth (Investigator 01)
Semmens, James (Investigator 02)
Preen, David (Investigator 03)
Glover, John (Investigator 04)

Status	Finished
Effective start/end date	31/12/06 → 31/12/10

Funding

NHMRC National Health and Medical Research Council : A$428,668.00

3 Article

Increased risk of 2-year death in patients who discontinued their use of statins
Seaman, K., Sanfilippo, F., Bulsara, M., Roughead, E., Kemp-Casey, A., Bulsara, C., Watts, G. F. & Preen, D., Apr 2021, In: PUNISHMENT & SOCIETY-INTERNATIONAL JOURNAL OF PENOLOGY. 26, 2, p. 95-105 11 p.
Research output: Contribution to journal › Article › peer-review
5 Citations (Web of Science)
Frequent general practitioner visits are protective against statin discontinuation after a Pharmaceutical Benefits Scheme copayment increase
Seaman, K. L., Sanfilippo, F. M., Bulsara, M. K., Brett, T., Kemp-Casey, A., Roughead, E. E., Bulsara, C. & Preen, D. B., Jun 2020, In: Australian Health Review. 44, 3, p. 377-384 8 p.
Research output: Contribution to journal › Article › peer-review
1 Citation (Scopus)
Predictors of ceasing or reducing statin medication following a large increase in the consumer copayment for medications: a retrospective observational study
Seamon, K., Sanfilippo, F., Bulsara, M., Roughead, L., Kemp-Casey, A., Bulsara, C., Watts, G. F. & Preen, D., 10 Mar 2020, In: Public Health Research & Practice. 30, 1, e29121905.
Research output: Contribution to journal › Article › peer-review

Open Access
7 Citations (Scopus)